This compound is a peracetylated glucopyranoside derivative featuring a chlorophenyl and a hydroxyphenylmethyl substituent. It is used as a pharmaceutical intermediate in the synthesis of larger active molecules.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1079083-63-8
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
pharmaceutical intermediate for dapagliflozin
2-(7-hydroxynaphthalen-1-yl)acetonitrile
Agomelatine impurity and intermediate
(1S,3R)-3-Hydroxycyclopentanecarboxylic acid
Pharmaceutical intermediate
N,N-Dimethylethylenediamine
pharmaceutical intermediate
Propanediamide
pharmaceutical intermediate
Beta-L-Xylopyranoside, methyl 5-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-1-thio-, 2,3,4-triacetate, (5S)-
n.a
(2S,3S,4R,5S,6R)-2-(3-(4-chlorobenzyl)-4-methylphenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate
Pharmaceutical intermediate
Dapagliflozin
active pharmaceutical ingredient
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-hydroxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate
IPPDHWALLUPDNH-MMKSVXGCSA-N
CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)C2=CC(=C(C=C2)Cl)CC3=CC=C(C=C3)O)OC(=O)C)OC(=O)C)OC(=O)C